NCT05620043View on ClinicalTrials.gov

Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

July 25, 2023

Study Completion Date

November 6, 2023

Conditions
Gene Expression
Interventions
DEVICE

Sculptra

Biostimulator

DEVICE

Radiesse Plus

Semi-permanent filler

Trial Locations (1)

33173

Miami Dermatology & Laser Institute, Miami

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT05620043 - Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler | Biotech Hunter | Biotech Hunter